Theratechnologies (THTX) Competitors

Theratechnologies (NASDAQ:THTX) and Zevra Therapeutics (NASDAQ:ZVRA) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their profitability, institutional ownership, risk, valuation, analyst recommendations, media sentiment, community ranking, dividends and earnings.

Do insiders & institutionals believe in THTX or ZVRA?

35.0% of Zevra Therapeutics shares are owned by institutional investors. 2.4% of Zevra Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Which has stronger valuation & earnings, THTX or ZVRA?

Theratechnologies has higher revenue and earnings than Zevra Therapeutics. Theratechnologies is trading at a lower price-to-earnings ratio than Zevra Therapeutics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Theratechnologies	$88.67M	1.31	-$23.96M	-$0.08	-31.63
Zevra Therapeutics	$40.59M	12.62	-$46.05M	-$1.90	-4.93

Does the MarketBeat Community prefer THTX or ZVRA?

Zevra Therapeutics received 8 more outperform votes than Theratechnologies when rated by MarketBeat users. Likewise, 95.12% of users gave Zevra Therapeutics an outperform vote while only 54.39% of users gave Theratechnologies an outperform vote.

Company	Underperform	Outperform
Theratechnologies	Outperform Votes 31 54.39%	Underperform Votes 26 45.61%
Zevra Therapeutics	Outperform Votes 39 95.12%	Underperform Votes 2 4.88%

Do analysts prefer THTX or ZVRA?

Zevra Therapeutics has a consensus target price of $22.29, indicating a potential upside of 137.84%. Given Zevra Therapeutics' higher probable upside, analysts clearly believe Zevra Therapeutics is more favorable than Theratechnologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Theratechnologies	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	2 Strong Buy rating(s)	4.00
Zevra Therapeutics	0 Sell rating(s)	0 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	3.11

Does the media refer more to THTX or ZVRA?

In the previous week, Zevra Therapeutics had 5 more articles in the media than Theratechnologies. MarketBeat recorded 6 mentions for Zevra Therapeutics and 1 mentions for Theratechnologies. Theratechnologies' average media sentiment score of 1.87 beat Zevra Therapeutics' score of 1.39 indicating that Theratechnologies is being referred to more favorably in the media.

Company	Overall Sentiment
Theratechnologies	Very Positive
Zevra Therapeutics	Positive

Is THTX or ZVRA more profitable?

Theratechnologies has a net margin of -3.75% compared to Zevra Therapeutics' net margin of -342.63%. Theratechnologies' return on equity of 0.00% beat Zevra Therapeutics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Theratechnologies	-3.75%	N/A	-4.31%
Zevra Therapeutics	-342.63%	-159.54%	-51.50%

Which has more risk & volatility, THTX or ZVRA?

Theratechnologies has a beta of 0.6, meaning that its stock price is 40% less volatile than the S&P 500. Comparatively, Zevra Therapeutics has a beta of 2.01, meaning that its stock price is 101% more volatile than the S&P 500.

Summary

Zevra Therapeutics beats Theratechnologies on 10 of the 19 factors compared between the two stocks.